Neelakantan Vijayalakshmi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Neelakantan Vijayalakshmi has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Ganesharaja Selvaluxmy
Department of Radiation Oncology, Cancer Institute (WIA), Chennai, India
2 shared publications - Kesavan Sabitha
Department of Molecular Oncology, Cancer Institute (WIA), 38, Sardar Patel Road, Chennai, 600036, India
2 shared publications - Mayil Vahanan Bose
Department of Molecular Oncology, Cancer Institute (WIA), Chennai, India
2 shared publications - Sundersingh Shirley
Department of Oncopathology, Cancer Institute (WIA), 38, Sardar Patel Road, Chennai 600036, Tamilnadu, India
2 shared publications - Thangarajan Rajkumar
Department of Molecular Oncology, Cancer Institute (WIA), Chennai, India
2 shared publications - Gopisetty Gopal
Department of Molecular Oncology, Cancer Institute (WIA), Chennai, India
1 shared publication
Latest Publications
- Open Access
- 22 February 2011
- Published by Springer Nature in BMC Cancer
- Vol. 11 (1) , 80
Identification and validation of genes involved in cervical tumourigenesis
Cervical cancer is the most common cancer among Indian women. This cancer has well defined pre-cancerous stages and evolves over 10-15 years or more. This study was undertaken to identify differentially expressed genes between normal, dysplastic and invasive cervical cancer.
- 22 February 2011
- Published by Springer Nature in BMC Cancer
- Vol. 11 (1) , 80
Open AccessIdentification and validation of genes involved in cervical tumourigenesis
Cervical cancer is the most common cancer among Indian women. This cancer has well defined pre-cancerous stages and evolves over 10-15 years or more. This study was undertaken to identify differentially expressed genes between normal, dysplastic and invasive cervical cancer.
- Open Access
- 15 October 2009
- Published by Springer Nature in BMC Cancer
- Vol. 9 (1) , 365
A 7 gene expression score predicts for radiation response in cancer cervix
Cervical cancer is the most common cancer among Indian women. The current recommendations are to treat the stage IIB, IIIA, IIIB and IVA with radical radiotherapy and weekly cisplatin based chemotherapy. However, Radiotherapy alone can help cure more than 60% of stage IIB and up to 40% of stage IIIB patients.
- 15 October 2009
- Published by Springer Nature in BMC Cancer
- Vol. 9 (1) , 365
Open AccessA 7 gene expression score predicts for radiation response in cancer cervix
Cervical cancer is the most common cancer among Indian women. The current recommendations are to treat the stage IIB, IIIA, IIIB and IVA with radical radiotherapy and weekly cisplatin based chemotherapy. However, Radiotherapy alone can help cure more than 60% of stage IIB and up to 40% of stage IIIB patients.